Clinical implications of globally emerging azole resistance in Aspergillus fumigatus
Clinical implications of globally emerging azole resistance in Aspergillus fumigatus
About this item
Full title
Author / Creator
Publisher
England: The Royal Society
Journal title
Language
English
Formats
Publication information
Publisher
England: The Royal Society
Subjects
More information
Scope and Contents
Contents
Aspergillus fungi are the cause of an array of diseases affecting humans, animals and plants. The triazole antifungal agents itraconazole, voriconazole, isavuconazole and posaconazole are treatment options against diseases caused by Aspergillus. However, resistance to azoles has recently emerged as a new therapeutic challenge in six continents. Alt...
Alternative Titles
Full title
Clinical implications of globally emerging azole resistance in Aspergillus fumigatus
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5095539
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5095539
Other Identifiers
ISSN
0962-8436
E-ISSN
1471-2970
DOI
10.1098/rstb.2015.0460
